Darolutamide Impurity 2
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Darolutamide Impurity 2

● In Stock

Catalogue No.:VE0023423
CAS No.:N/A
Mol. Formula:C26H23ClN6O3
Mol. Weight:503.0 g/mol

Additional information on Darolutamide Impurity 2

Parent drug

Darolutamide

IUPAC Name

N-(2-(3-(3-chloro-4-cyanophenyl)-1H-pyrazol-1-yl)propyl)-N-(2-formylphenyl)-5-(1-hydroxyethyl)-1H-pyrazole-3-carboxamide

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C(C1=NNC(C(O)C)=C1)N(CC(N2N=C(C3=CC=C(C#N)C(Cl)=C3)C=C2)C)C4=CC=CC=C4C=O

InChI

InChI=1S/C26H23ClN6O3/c1-16(33-10-9-22(31-33)18-7-8-19(13-28)21(27)11-18)14-32(25-6-4-3-5-20(25)15-34)26(36)24-12-23(17(2)35)29-30-24/h3-12, 15-17, 35H, 14H2, 1-2H3, (H, 29, 30)

Description

The Darolutamide Impurity 2 standard is a well-characterized compound that aligns with key regulatory guidelines | including USP | EMA | JP | and BP. It plays a crucial role in analytical method development | method validation (AMV) | and quality control (QC) processes | particularly in the manufacturing of Darolutamide. This impurity standard is valuable for both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA) | ensuring reliable and precise analytical outcomes. To further support research and development | it comes with a comprehensive Structure Elucidation Report (SER) | providing detailed insights for advanced analysis.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url